| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US9301948 | INTELGENX CORP | Instantly wettable oral film dosage form without surfactant or polyalcohol |
Jul, 2034
(10 years from now) | |
Rizafilm is owned by Intelgenx Corp.
Rizafilm contains Rizatriptan Benzoate.
Rizafilm has a total of 1 drug patent out of which 0 drug patents have expired.
Rizafilm was authorised for market use on 14 April, 2023.
Rizafilm is available in film;oral dosage forms.
The generics of Rizafilm are possible to be released after 30 July, 2034.
Drugs and Companies using RIZATRIPTAN BENZOATE ingredient
Market Authorisation Date: 14 April, 2023
Treatment: NA
Dosage: FILM;ORAL
More Information on Dosage
RIZAFILM family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic